encyclopedia of medical concepts
ψ 
ψ 
ψ 
ψ 
ψ 
ψ 
ψ 

Barth Syndrome

More information in Books or onNLM PubMed
Definition: Rare congenital X-linked disorder of lipid metabolism. Barth syndrome is transmitted in an X-linked recessive pattern. The syndrome is characterized by muscular weakness, growth retardation, DILATED CARDIOMYOPATHY, variable NEUTROPENIA, 3-methylglutaconic aciduria (type II) and decreases in mitochondrial CARDIOLIPIN level. Other biochemical and morphological mitochondrial abnormalities also exist.     
See Also Isolated Noncompaction of the Ventricular Myocardi
Other names type IIs, MGA; type IIs, 3-methylglutaconicaciduria; type II, MGA; type II, 3-methylglutaconicaciduria; type 2s, 3-methylglutaconicaciduria; type 2, 3-methylglutaconicaciduria; Syndrome, Barth; MGA type IIs; 3-methylglutaconicaciduria type IIs; 3-methylglutaconicaciduria type 2s; 3 methylglutaconicaciduria type 2; MGA Type 2; MGA type II; 3-methylglutaconicaciduria type II; 3-methylglutaconicaciduria type 2
 
SubstanceCAS Registry & nameCategoriesSource
Dilated cardiomyopathy, neutropenia, skeletal myopathy, and abnormal mitochondria  0   *Barth Syndrome.

To share this definition, click "text" (Facebook, Twitter) or "link" (blog, mail) then paste text link
Ads by Google

Sources: NLM Medical Subject Headings, NIH UMLS, Drugs@FDA, FDA AERS original data copyright United States Government. No endorsement implied. Last modified 6/6/2012

Warning: the drugs or drug combinations referred to here may be similar or related, but are not be the same ones and may not have the same pharmacological action as other substances described on the same page or in the same row. Please refer to product monograph or to your doctor
This website is accredited by Health On the Net Foundation. Click to verify.
We comply with the HONcode standard for trustworthy health information: verify here.
About Reference.MD Privacy